Hong Kong
· Delayed Price · Currency is HKD CanSino Biologics Statistics
Total Valuation
HKG:6185 has a market cap or net worth of HKD 11.11 billion. The enterprise value is 9.24 billion.
| Market Cap | 11.11B |
| Enterprise Value | 9.24B |
Important Dates
The last earnings date was Tuesday, April 29, 2025.
| Earnings Date | Apr 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:6185 has 247.04 million shares outstanding. The number of shares has decreased by -1.38% in one year.
| Current Share Class | 132.67M |
| Shares Outstanding | 247.04M |
| Shares Change (YoY) | -1.38% |
| Shares Change (QoQ) | -7.33% |
| Owned by Insiders (%) | 31.39% |
| Owned by Institutions (%) | 6.80% |
| Float | 165.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 139.49 |
| PS Ratio | 11.92 |
| PB Ratio | 2.12 |
| P/TBV Ratio | 2.16 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -39.10 |
| EV / Sales | 9.91 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.65, with a Debt / Equity ratio of 0.27.
| Current Ratio | 2.65 |
| Quick Ratio | 2.41 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -32.46 |
Financial Efficiency
Return on equity (ROE) is -4.31% and return on invested capital (ROIC) is -2.54%.
| Return on Equity (ROE) | -4.31% |
| Return on Assets (ROA) | -2.14% |
| Return on Invested Capital (ROIC) | -2.54% |
| Return on Capital Employed (ROCE) | -4.48% |
| Revenue Per Employee | 623,793 |
| Profits Per Employee | -158,122 |
| Employee Count | 1,494 |
| Asset Turnover | 0.11 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +54.52% in the last 52 weeks. The beta is 1.24, so HKG:6185's price volatility has been higher than the market average.
| Beta (5Y) | 1.24 |
| 52-Week Price Change | +54.52% |
| 50-Day Moving Average | 33.43 |
| 200-Day Moving Average | 27.81 |
| Relative Strength Index (RSI) | 48.79 |
| Average Volume (20 Days) | 1,110,554 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:6185 had revenue of HKD 931.95 million and -236.23 million in losses. Loss per share was -0.97.
| Revenue | 931.95M |
| Gross Profit | 956.06M |
| Operating Income | -300.90M |
| Pretax Income | -239.00M |
| Net Income | -236.23M |
| EBITDA | n/a |
| EBIT | -300.90M |
| Loss Per Share | -0.97 |
Balance Sheet
The company has 3.31 billion in cash and 1.44 billion in debt, giving a net cash position of 1.87 billion or 7.59 per share.
| Cash & Cash Equivalents | 3.31B |
| Total Debt | 1.44B |
| Net Cash | 1.87B |
| Net Cash Per Share | 7.59 |
| Equity (Book Value) | 5.25B |
| Book Value Per Share | 22.75 |
| Working Capital | 2.76B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 102.59%, with operating and profit margins of -32.29% and -25.35%.
| Gross Margin | 102.59% |
| Operating Margin | -32.29% |
| Pretax Margin | -25.65% |
| Profit Margin | -25.35% |
| EBITDA Margin | n/a |
| EBIT Margin | -32.29% |
| FCF Margin | n/a |
Dividends & Yields
HKG:6185 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.38% |
| Shareholder Yield | 1.38% |
| Earnings Yield | -2.13% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:6185 has an Altman Z-Score of 1.94. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.94 |
| Piotroski F-Score | n/a |